ea0063p1045 | Interdisciplinary Endocrinology 2 | ECE2019
Anderson Cian
, Sheehan David
, Ronan Karine
, Othman Elly Hanis Che
, McKenna Susan
, McDermott Ray
, Westrup Jennifer
, Griffin Margaret
Background: Immune related adverse events (iRAEs) of the endocrine system are commonly recognised in Checkpoint Inhibitor Therapy treatment with current research suggesting clinically significant endocrinopathies occur in 10%. As the use of these drugs continues to rise, so too does the importance of routine endocrine monitoring in order to avoid potentially life-threatening adverse-events.Aims: To establish the frequency, severity, management and outcom...